Pediatric to adult care transfer in rare liver diseases: Recommendations based on insights from a European omnistakeholder event
Year: 2025
Type: article
Abstract: Background & Aims The transfer journey from pediatric to adult care services of young people with rare liver diseases poses significant challenges and is an underexplored research area. This study examined the critical aspects of, and opportunities for, transfer journey management for these young people in Europe. Methods In total, 72 individuals, representing 13 countries, participated in an omnistakeholder workshop on 17–18 March 2023. A standardized workshop methodology was used to discuss critical aspects and actions over nine focus sessions. The themes of these sessions were identified by engaging with healthcare providers, young people, and parents. Results ( i.e. aspects receiving >25% of the votes) were ranked based on importance and validated by the European Reference Network of Hepatological Diseases (ERN RARE-LIVER) youth panel. Results Our findings revealed that the critical aspects of transfer journey management predominantly revolved around the transfer itself. Most of the critical aspects and actions were related to improving communication ( e.g. allocating sufficient time, 81% of votes; giving consistent information, 43%; and discussing communication preferences, 100%), relational continuity ( e.g. appointing a transition person to liaison between stakeholders, 79%), and management continuity ( e.g. using a transfer document, 60%). Our results also underscored the importance of peer mentorship programs (100%), informing young people about the transfer process (85%), and implementing joint consultations (93%). Conclusions Current literature and guidelines on ‘transition' might not fully address real-world challenges in rare liver diseases, particularly those concerning maintaining continuity of care during the actual transfer process. Future research should examine the effectiveness of strategies aimed at enhancing communication and continuity of care throughout the transfer journey, focusing on stakeholder experience. Impact and implications This international omnistakeholder workshop explored challenges and opportunities in managing transfer journeys for young people with rare liver diseases. By emphasizing practical implications (leading to actions), it provides a benchmark for improving transfer journeys worldwide, applicable to not only rare liver diseases, but possibly also common liver or other rare diseases. Our findings underscore the fundamental importance of the transfer itself in maintaining continuity of care. The critical aspects identified center around informative, relational, and management continuity of care and have been transformed into minimal criteria.
Source: JHEP Reports
Authors: Karsten Vanden Wyngaert, Janne Suykens, Deirdre Kelly, Isabel Goncalves, Ena Lindhart Thomsen, Jose Willemse, Zoe Mariño, João Madaleno, Jemma Day, Marianne Samyn, Mohamed Ali, Marianne Hørby Jørgensen, Eva Goossens, Johan De Munter, Anneloes Van Staa, Jo Wray, Panayiota Protopapa, Ansgar Lohse, Ruth De Bruyne
Institutions: Ghent University Hospital, Ghent University, ERN RARE-LIVER, Birmingham Women's Hospital, Unidade Local de Saúde de Coimbra, Copenhagen University Hospital, Rigshospitalet, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, King's College Hospital, Antwerp University Hospital, Rotterdam University of Applied Sciences, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust, Archbishop Makarios III Hospital, University Medical Center Hamburg-Eppendorf
Language: English
Subfield: Speech and Hearing
Field: Health Professions
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,110
OpenAlex ID: W4408940931
